0
 

GlaxoSmithKline plc-Company profile, Business Overview, Financial Performance, Operating Segments, Strategic Moves, and Competitive Intelligence Report

  • ID: CPS__175877
  • July 2017
  • 8 pages
  • Price: $ 95
 
 

COPD and asthma devices, also known as pulmonary drug delivery devices, are used as a permanent treatment or rescue therapy for respiratory diseases and other related ailments. It is the most advanced mode of drug administration in which the drug is directly delivered to the lungs to provide a systemic effect.

 

TOC

1.1 Company Overview

1.2 Company Snapshot

1.3 Operating Business Segment

1.4 Business Performance

1.5 Key Strategic moves and Development

 

LIST OF TABLES AND FIGURES

TABLE 1. GLAXOSMITHKLINE PLC SNAPSHOT

TABLE 2. GLAXOSMITHKLINE PLC OPERATING SEGEMENTS

FIG. 1. GLAXOSMITHKLINE PLC, REVENUE 2013-2015 ($MILLION)

FIG. 2. GLAXOSMITHKLINE PLC, REVENUE BY GEOGRAPHY 2015 (%)

FIG. 3. GLAXOSMITHKLINE PLC REVENUE BY BUSINESS SEGMENTS, 2015 (%)

FIG. 4. SWOT ANALYSIS OF GLAXOSMITHKLINE PLC

Purchase Options

 

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers